Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

BioLife Solutions Inc nudges higher after 2016 revenue growth

Thursday, January 12, 2017 9:17
% of readers think this story is Fact. Add your two cents.

Biotech firm BioLife Solutions Inc (NASDAQ: BLFS) saw a 24% increase in its biopreservation product sales in the fourth quarter compared to the same period of 2015.

Sales reached a new high of $2.2 million in the period, it said, as it revealed an overall 2016 revenue of $8.2 million – a 28% increase on the previous year.

The firm’s technology allows  companies and clinical researchers to improve shelf life and post-preservation viability and function of cells, tissues, and organs.

Mike Rice, BioLife’s chief executive, said: “2016 was another strong year of execution that broadened the biopreservation media franchise we have built in the regenerative medicine market.

“Our efforts should be further rewarded in 2017 with possible customer regulatory approvals of their cell-based therapies. Customer adoption of the evo Smart Shipper and biologistex SaaS is anticipated this year and our recent JV restructuring was an important accomplishment to enable growth without BioLife having to raise additional capital.”

 Shares in New York added 1.68% to US$1.82 each.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.